Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Nov 26;13:995–1005. doi: 10.2147/JIR.S268484

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2020 Sznurkowska et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

Comparison of circulating and intestinal Tregs in the studied group (left panel) and the control group (right panel). (A) Circulating and intestinal Tregs expressed as a percentage of CD4⁺ lymphocytes in the IBD group (left side) and the controls (right side). (B) Circulating and intestinal Helios⁺ Tregs expressed as a percentage of all Tregs in the IBD group (left side) and the controls (right side). (C) Circulating and intestinal Nrp-1⁺ Tregs expressed as a percentage of all Tregs in the IBD group (left side) and the controls (right side). *Statistically significant difference. Individual results are shown as dots (●)/squares (■). Horizontal lines indicate median values.

Abbreviations: IBD, patients with inflammatory bowel disease; C, control group; ns, not significant.